Kresmed Sp. z o. o.

Bialystok 15-481

2 studies enrolling now · 2 studies all time

What they study most

Metabolic Dysfunction-Associated Steatotic Liver Disease, Obesity, Type 2 Diabetes

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight — Recruiting now